ArticleJournal of neuro-oncology2025
Bevacizumab exerts dose-dependent risk for intracranial hemorrhage in patients with malignant gliomas.
Sanghee Lim et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleJournal of neuro-oncology2025
Sanghee Lim et al.PubMed ↗Publisher ↗
No numbers read from the abstract.